Recombinant Escherichia coli Metalloprotease/StcE His, CF

R&D Systems, part of Bio-Techne | Catalog # 11406-MP

His-tag
R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
11406-MP-050
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

E. coli

Accession #

O82882.2

Conjugate

Unconjugated

Applications

Enzyme Activity

View all StcE Proteins and Enzymes »

Product Specifications

Source

E. coli-derived e. coli StcE protein
Ala36-Lys898 with a N-terminal Met and 6-His tag

Purity

>85%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Met & Arg415

Predicted Molecular Mass

97 kDa & 54 kDa

SDS-PAGE

86-95 & 53-58 kDa, under reducing conditions.

Activity

Measured by its ability to cleave Recombinant CD45 Protein at specific O-glycan sites.
One μg of Recombinant E. coli StcE will cleave >60% of Recombinant CD45 Protein with labeled O-glycan  (Catalog # 1430-CD), as measured under the described conditions.

Scientific Data Images for Recombinant Escherichia coli Metalloprotease/StcE His, CF

Recombinant E. coli StcE His-tag Enzyme Activity Diagram.

Recombinant E. coli StcE His-tag cleaves glycoproteins C-terminally to glycosylated Ser/Thr residues that are near the cleavage residue. Specificity for O-glycan complexity is broad. For simplicity not all O-glycans may be represented.

Recombinant E. coli StcE His-tag Enzyme Activity Assay.

Recombinant Human CD45 Protein, CF (1430-CD) was first cleaved using Recombinant E. coli StcE (Cat # 11406-MP). Following cleavage, Recombinant C. perfringens Neuraminidase Protein, CF (5080-NM) was used to remove intact Sialic Acid. O-glycans were then labeled using Recombinant Human ST3GAL2 Protein, CF (7275-GT) and CMP-Cy3-Sialic Acid (ES402). Samples were then run on a SDS-PAGE gel and imaged using the green fluorescent channel.

Formulation, Preparation and Storage

11406-MP
Formulation Supplied as a 0.2 μm filtered solution in Tris and NaCl.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: StcE

Recombinant E. coli StcE (secreted protease of C1-esterase inhibitor) is a zinc-dependent, monomeric mucinase from Enterohaemorrhagic Escherichia coli (EHEC). EHEC is a major foodborne pathogen that must penetrate a thick mucus layer for effective infection. StcE has three distinct globular domains with non-catalytic globular domains at the N- and C-terminus and the catalytic metalloprotease domain in the middle. This open arrangement is thought to allow for additional regulatory functions and flexibility to recognize large O-glycosylated substrates (1, 2). StcE is secreted via the type II general secretory pathway during infection as a major virulence factor due to its protease-meditated activity towards heavily glycosylated proteins with high levels of O-linkages that play a host defensive role such as mucin 7 and glycoprotein 340, in addition to C1-esterase inhibitor, a regulator of inflammation pathways (2). StcE has also been implicated in cleavage of glycoproteins found on the surface of various cells such as intestinal epithelial cells and neutrophils, where it has been shown to lead to depression of neutrophil migration during infection (3, 4). StcE has been proposed as a treatment for cystic fibrosis as it is has been shown to loosen mucus in affected patients (1, 4). In addition, StcE has been proposed as a useful tool for the analysis of mucin-domain glycoproteins known to be important in several human diseases including cancer (5-8). StcE has a broad specificity from simple to complex O-glycans, with specificity for a discrete peptide- and glycan-based motif that allows its utilization in glycoproteomic mapping of mucin glycosites or enrichment of mucins (5-8). The activity of recombinant StcE is demonstrated in an electrophoretic gel mobility shift assay using enzymatically fluorophore labeled mucin-like glycoproteins.

References

  1. Yu, A. et al. (2012). Structure. 20:707.
  2. Grys, TE. et al. (2005). Infection and Immunity. 73:1295.
  3. Furniss, RCD. et al. (2018). J Biol. Chem. 293:17188.
  4. Hews, CL et al. (2017). Cell. Microbiol. 19:e12717.
  5. Malaker, SA.  et al. (2019). Proc. Natl. Acad. Sci. USA. 116:7278.
  6. Taleb, V. et al. (2022). Nat. Commun. 13:4324.
  7. Shon, DJ.  et al. (2020). Proc. Natl. Acad. Sci. USA. 117:21299.
  8. Pluvinage, B. et al. (2021). Proc. Natl. Acad. Sci. USA. 118:e2019220118.

Long Name

Metalloprotease stcE

UniProt

O82882.2

Additional StcE Products

Product Documents for Recombinant Escherichia coli Metalloprotease/StcE His, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Escherichia coli Metalloprotease/StcE His, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.